Status:
TERMINATED
ChloraPrep Versus Betadine for Elective Knee Replacement Surgery
Lead Sponsor:
Central DuPage Hospital
Conditions:
Arthroplasty, Knee Replacement
Replacement, Total Knee
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will enroll patients who will be receiving primary total knee replacements. Subjects will be randomized into two groups: Betadine surgical scrub preparation and ChloraPrep preparation prior...
Detailed Description
Swabs will be taken over the operative knee by study personnel for a bacterial colony count immediately before surgical site preparation is started, after the surgery prep is complete, and 24 hours po...
Eligibility Criteria
Inclusion
- Scheduled to undergo primary total knee arthroplasty
- Age 18 or over
Exclusion
- Inability to provide informed consent or to comply with study assessments due to cognitive impairment or geographic distance
- Age 17 or younger
- Allergies to chlorhexadine gluconate or povidone iodine
- Topical antimicrobial use within 14 days of surgery
- Any active dermatoses or open wounds over the operative site
- Any condition requiring antibiotics 14 days prior to arriving for surgery
- Patients with chronic immunosuppression (such as HIV/AIDS)
- Unable to adhere to follow up schedule and treatment
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT01184196
Start Date
November 1 2009
End Date
December 1 2012
Last Update
April 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central DuPage Hospital
Winfield, Illinois, United States, 60190